학술논문
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
Document Type
Brief Communication
Author
Singh, Kirit; Hotchkiss, Kelly M.; Parney, Ian F.; De Groot, John; Sahebjam, Solmaz; Sanai, Nader; Platten, Michael; Galanis, Evanthia; Lim, Michael; Wen, Patrick Y.; Minniti, Giuseppe; Colman, Howard; Cloughesy, Timothy F.; Mehta, Minesh P.; Geurts, Marjolein; Arrillaga-Romany, Isabel; Desjardins, Annick; Tanner, Kirk; Short, Susan; Arons, David; Duke, Elizabeth; Wick, Wolfgang; Bagley, Stephen J.; Ashley, David M.; Kumthekar, Priya; Verhaak, Roel; Chalmers, Anthony J.; Patel, Anoop P.; Watts, Colin; Fecci, Peter E.; Batchelor, Tracy T.; Weller, Michael; Vogelbaum, Michael A.; Preusser, Matthias; Berger, Mitchel S.; Khasraw, Mustafa
Source
Nature Medicine. 29(10):2402-2405
Subject
Language
English
ISSN
1078-8956
1546-170X
1546-170X
Abstract
A breakthrough in drug discovery for glioblastoma requires serial collection of tissue from the central nervous system via window of opportunity trials